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Abstract
The early stages of Alzheimer’s disease are marked by synaptic dysfunction and loss. This process results from the
disassembly and degradation of synaptic components, in particular of scaffolding proteins that compose the post-synaptic
density (PSD), namely PSD95, Homer and Shank. Here we investigated in rat frontal cortex dissociated culture the
mechanisms involved in the downregulation of GKAP (SAPAP1), which links the PSD95 complex to the Shank complex and
cytoskeletal structures within the PSD. We show that Ab causes the rapid loss of GKAP from synapses through a pathway
that critically requires cdk5 activity, and is set in motion by NMDAR activity and Ca
2+ influx. We show that GKAP is a direct
substrate of cdk5 and that its phosphorylation results in polyubiquitination and proteasomal degradation of GKAP and
remodeling (collapse) of the synaptic actin cytoskeleton; the latter effect is abolished in neurons expressing GKAP mutants
that are resistant to phosphorylation by cdk5. Given that cdk5 also regulates degradation of PSD95, these results underscore
the central position of cdk5 in mediating Ab-induced PSD disassembly and synapse loss.
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Introduction
In the early stages of Alzheimer’s disease (AD), soluble
oligomers of amyloid-b (Ab) bind to synaptic sites, derange
synaptic plasticity and ultimately cause the loss of synapses [1–4].
Decrease in synapse number and the ensuing derangement in
brain connectivity are the best predictors of the onset and the
progression of cognitive impairment in AD [5,6]. While both the
pre- and post-synaptic compartments are affected by Ab peptides
[7], loss of dendritic spines is the most prominent effect of Ab
observed in transgenic animals [8] and in neurons in culture [9–
11]. Sequentially interconnected molecular events underlie the
process leading to spine demise upon exposure to Ab: endocytosis
of synaptic AMPA and NMDA glutamate receptors [9,10,12,13],
retro-translocation of adhesion molecules and kinases [10,14], and
depolymerization of actin structures [10,14,15].
Major reorganization of the scaffold proteins that constitute the
post-synaptic density (PSD) [16] is observed: PSD-95 undergoes
degradation after phosphorylation by cdk5, and activation of
multiple signaling pathways lead to the dispersal of Homer1 and
Shank1 clusters [13,17]. Since the PSD plays a pivotal role in the
formation and maintenance of spines [16], Ab-induced PSD
disassembly is likely to represent a point beyond which synaptic
loss becomes inevitable.
GKAP/SAPAP family proteins serve a crucial function in the
organization of the PSD by effectively bridging PSD-95 and Shank
complexes and thus, bringing glutamate receptors (part of the
PSD-95 complex), cytoskeletal and signaling (partners of Shank
proteins) proteins in close proximity of each other [18–21]. The
loss of SAPAP interferes with the ultrastructural organization of
the PSD and maturation and plasticity of synapses [22]. GKAP,
the shortest and most abundant SAPAP1 isoform [18,23], is
located in the deepest layer of the PSD [24] where, in addition to
PSD-95 and Shank, it directly interacts with cytoskeletal structures
[25–27]. Given that GKAP resides at an interface where different
scaffold modules (the PSD and the synaptic cytoskeleton) interact,
understanding how GKAP is regulated by Ab can be expected to
provide critical insights into how amyloid peptides lead to PSD
disassembly and cytoskeletal derangement. In this investigation of
the fate and the regulation of GKAP by soluble Ab peptide, we
identify a crucial role of cdk-5 in triggering GKAP ubiquitination
and degradation and, in turn, a major role of cdk5-GKAP
signaling in the disassembly of synaptic actin structures.
Results
Ab peptides disassembles synaptic GKAP clusters
To investigate the effect Ab1–40 peptide on the scaffold protein
GKAP, dissociated cultures of frontal cortical neurons were
treated with soluble Ab40 peptide; under the conditions used,
Ab40 was detectable in the culture medium largely as low-n
oligomers with MW ranging from 4 to 16 KDa (monomer to
tetramers: Figure S1). Synapses were identified by the presynatic
marker synaptophysin, and levels of GKAP were evaluated by
PLoS ONE | www.plosone.org 1 July 2011 | Volume 6 | Issue 7 | e23097immunostaining. At baseline, GKAP displayed an intense,
punctate staining along dendrites with 87.4% (68.3) of GKAP
clusters juxtaposed to synaptophysin-positive puncta. The size of
GKAP synaptic clusters progressively decreased to 59.4%,
54.461.9% and 43.565.4% of baseline following exposure to
Ab40 for 1, 6 and 24 h, respectively (Fig. 1 A, B), in a dose-
dependent manner (Figure S2). Although smaller in size, GKAP
cluster density was apparently increased after 1 and 6 h of
treatment (from 12.464 clusters per 10 mm of dendrite length to
18.563.5 and 21.165.3 after 1 and 6 h, respectively; Fig. 1C) but
was markedly decreased after 24 h (7.362.1 clusters/10 mm). At
closer inspection, whereas single GKAP clusters were juxtaposed
to synaptophysin puncta at baseline, multiple small GKAP clusters
were found to face single synaptophysin cluster at the 1 and 6 h
timepoints, suggesting that the small clusters were remnants of
larger PSD. Confirming the overall decrease in GKAP caused by
Ab, the percentage of synapses (identified by synaptophysin
immunostaining) containing detectable levels of GKAP fell
progressively (82.567.7%, 67.3612.1% and 47.264.4%, respec-
tively; p,0.001) (Fig. 1A, D). Of note, 10–15% of neurons in our
cultures were not affected by Ab (in line with what previously
reported, see [10]). Hippocampal neurons treated with oligomers
of Ab1–42 for 1,6 and 24 h displayed larger decreases in GKAP
cluster size (respectively, 47.4%64.4, 34.961.9% and 23.562.4%
of baseline; see Fig. 1 E, F). Notably, exposure to Ab42 produced a
small increase in GKAP cluster density (from 12.464 to 15.363.7
clusters per 10 mm of dendrite length) after 1 h; thereafter, GKAP
size density was markedly reduced (6.464.3 and 5.261.1 at 6 and
24 h, respectively; Fig. 1G). Likewise, the relative number of
GKAP-positive synapses were reduced to 80.565.7%,
57.3610.1% and 36.265.4% after 1, 6 and 24 h of treatment
with Ab42 (Fig. 1H). The downregulation of GKAP by Ab was
observed in whole-cell protein extracts by immunoblotting. GKAP
levels were not decreased (94.464.0% of baseline) after 30 min of
treatment, but a small decrease was observed at 1 h (82.3614.3%,
p,0.05) and significant downregulation was seen after 3, 6, and
24 h (69.3614.2%; and 48.4621.3% and 50.3614.3% respec-
tively, p,0.05; Fig. 1E).
Inspection of the temporal pattern of synaptic GKAP loss within
the first hour of exposure to Ab revealed that, while GKAP cluster
size was unchanged at 15 and 30 min, GKAP cluster sizes were
significantly reduced from baseline size after 45 (81.469.5%) and
60 min (68.668.5%) (p#0.05; Fig. 1F,G). Similar temporal
dynamics of Ab-induced disassembly of the PSD was observed
by ultrastructural analyses (Fig. 1H): as compared to baseline
measures (3764 nm), PSD thickness was unaltered at 30 min
(3564 nm) but significantly reduced at 60 min (2763 nm;
p,0.05) after Ab application. Thus, both downregulation of
synaptic GKAP and the collapse of the PSD occur within 30–
60 min of exposure to Ab.
NMDAR activity is required for GKAP downregulation
NMDAR activity regulates synaptic localization and turnover
rates of PSD proteins such as PSD95 [13,28], Homer and Shank
[17,29]. Both, the NMDAR blocker MK801 (10 mM) and the
NR2B-specific blocker ifenprodil (10 mM) abolished Ab-induced
GKAP cluster disassembly, indicating the key role of activated
NMDAR in the process (Fig. 2A,B); in contrast, blockade of
AMPAR or VDCC with NQBX and verapamil, respectively, did
not prevent the actions of Ab (Figure S3A). The role for Ca
2+
influx in signaling downstream from the NMDAR was proven by
the observation that Ab-induced disassembly of GKAP clusters
was abolished under Ca
2+-free conditions or in the presence of a
Ca
2+ chelator (BAPTA-AM; Fig. 3A,B). On the other hand,
neither the src-family inhibitor SU6656 (10 mM) nor the tyrosine
phosphatase inhibitor Na3VO4 (100 mM) influenced GKAP loss
(Fig. S3B), ruling out involvement of the tyrosine kinase pathway
[30]. Taken together, these data show that an NMDAR-initiated,
Ca
2+-dependent signaling pathway is involved in the control of
GKAP downregulation.
Role of CaMKII in synaptic GKAP clustering, but not
downregulation
While diverse Ca
2+-dependent signaling pathways have been
implicated in the regulation of the localization, function and
turnover rates of PSD proteins [17,31,32], nothing is know about
the regulation of GKAP date. A screen of phospho-proteomic
databases of purified PSD [33–35] yielded 38 phospho-peptide hits
related to the GKAP sequence (Table S1). Annotation of these
peptides by applying two independent phosphorylation motif
prediction algorithms (Scansite: [36]; Phosida: [37]) identified a
number of kinases, including CaMKII, several isoforms of PKC,
PKA, PKB, CK1 and Cdk5 (Figure S4) that could potentially
target GKAP; however, several sites (9 with Phosida, 27 with
Scansite, 4 with both algorithms) could not be unambiguously
assigned to any individual kinase.
Initial investigations focused on CamKII since this kinase is
known to regulate the dynamics of PSD proteins, including SAP97
[38] and PSD-95 [39]. Notably, treatment of neurons with two
different peptide inhibitors of CaMKII alone caused a decrease in
GKAP cluster size (64.168.3% and 66.565.7% of baseline in the
presence of CamKII inhibitor I and Autocamtide, respectively,
Fig. 3A). Further, cotransfection of neurons with plasmids
encoding GKAP-GFP and a constitutively active mutant of
CaMKII (T286D) increased GKAP cluster sizes (142.469.6% of
control, GKAP-GFP/b-gal-expressing neurons, Fig. 3B), but did
not prevent the effects of Ab on synaptic GKAP (Fig. 3B). Thus,
CaMKII promotes the accumulation of GKAP in the synapse, but
plays no role in the downregulation of GKAP by Ab.
Cdk5 mediates Ab-induced GKAP downregulation
The involvement of kinase pathways identified by in silico
analysis as potential regulators of GKAP (see Table S1) was
screened using a pharmacological approach. Two cdk5 inhibitors,
roscovitine and the structurally unrelated PNU112455, abolished
Ab-induced GKAP degradation (Fig. 4A). In comparison,
inhibition of p38 (with SB2035) only partially attenuated the
actions of Ab (71.867.3%, SB+Ab vs SB alone, as compared with
53.763.4% in control+Ab vs control alone, p,0.05; Fig. 4A), and
blockade of PI-3K, ERK, JNK, PKC and PKA, with Wortman-
nin, UO126, AEG3482, Go ¨6893, and H89, respectively, had no
significant effect (Fig. S5A). The activation of cdk5 by Ab was
confirmed by monitoring the levels of cdk5 activator p35 and its
cleavage product p25 in whole-cell protein extracts; Ab treatment
upregulated p35 and strongly increased the levels of p25 (whose
upregulation is responsible for the disregulated activation of cdk5;
Fig. S5B); levels of cdk5 were unchanged.
The role of cdk5 was confirmed by co-transfecting cortical
neurons with GKAP-GFP and either cdk-5 or p35, its activating
partner. Overexpression of cdk5 or p35 led to a significant
decrease in GKAP-GFP cluster size (p,0.05), and significantly
potentiated the effects of Ab (Fig. 4B). Transfection of neurons
with cdk5-DN or sh-cdk5 plasmids resulted in GKAP-GFP clusters
that were markedly larger than at baseline (Fig. 4B). Notably, Ab
failed to influence GKAP-GFP clusters when cdk5 was depleted
using these approaches (Fig. 4B).
Cdk5 was found to have a role that extended beyond the
disassembly of GKAP clusters, namely in the regulation of overall
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PLoS ONE | www.plosone.org 2 July 2011 | Volume 6 | Issue 7 | e23097Figure 1. Ab causes the downregulation of GKAP. (A,B) Rat frontal cortical neurons were treated with soluble Ab40 (1 mM) for 1, 6, or 24 h and
immunostained for GKAP and the synaptic marker synaptophysin; a minimum of 600 synapses per timepoint were evaluated. GKAP cluster size was
decreased to 5969.3% (p,0.01) of baseline after 1 h, and to 54.461.9 and 43.65.4% after 6 and 24 h, respectively. Scale bars represent 5 mM for the
high magnification images and 20 mM for the low-magnification overview. (C,D) The density of GKAP clusters, albeit smaller in size, increased from
12.464 clusters/10 mm to 18.563.5 and 21.165.3 after 1 and 6 h, but significantly decreased to 7.362.1 after 24 h; likewise, the number of
synaptophysin puncta not matched with a GKAP puncta (an estimate of the number of synapses in which GKAP levels were undetectable) decreased
to 82.567.7% of the baseline after 1 h and to 67.3612.1% and 47.264.4% after 6 and 24 h, respectively; p,0.001. (E,F) Rat fronto-cortical neurons
were treated with soluble Ab42 (1 mM) oligomers for 1, 6, or 24 h and immunostained for GKAP and the synaptic marker synaptophysin; a minimum
of 600 synapses per timepoint were evaluated. Ab42 oligomers decreased the size of GKAP clusters to 47.4%64.4, 34.961.9% and 23.562.4% of
baseline after 1, 6 and 24 h, respectively; scalebar 5 mm. (G,H) Ab42 oligomers caused an apparent increase in GKAP cluster density (due to
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PLoS ONE | www.plosone.org 3 July 2011 | Volume 6 | Issue 7 | e23097GKAP protein levels. Specifically, roscovitine prevented the
reduction of GKAP levels in whole cell protein extracts after Ab
application (Fig. 4C). Since Ab-induced GKAP degradation was
proteasome-dependent (Figure S5C), we next tested the involve-
ment of cdk5 in GKAP ubiquitinylation by probing immunopre-
cipitated GKAP from vehicle- and Ab-treated cells with a poly-
ubiquitin antibody. Cells exposed to Ab displayed a stronger
polyubiquitinylated GKAP signal (Fig. 4D, lanes 1 and 2) whereas
roscovitine reduced baseline levels of ubiquitinylated GKAP and
markedly attenuated Ab-induced GKAP ubiquitinylation (Fig. 4D,
Figure 2. Ab-induced GKAP downregulation requires NMDAR activity and Ca
2+ influx. (A, B) Rat frontal cortical neurons were pretreated
with the non-specific NMDAR blocker MK801 (10 mM), the NR-2B specific blocker Ifenprodil (10 mM) or the Ca
2+ chelator BAPTA-AM (20 mM); in
independent experiments, neurons were exposed to Ab in Ca
2+-free medium. Both MK801 (94.966.6%, MK+Ab vs MK alone, p.0.05) and Ifenprodil
(93.565.5% Ife+Ab vs Ife alone, p.0.05) prevented GKAP degradation. Likewise, either BAPTA-AM (97.867.9% Bapta+Ab vs Bapta alone p.0.05) or
incubation in Ca
2+-free medium (93.667.8, Ca
2+-free medium+Ab vs Ca
2+-free medium alone) prevented Ab-induced downregulation of GKAP, even
though both treatments reduced themselves GKAP cluster size compared to control conditions (71.468.3 and 73.665.0 for Ca
2+-free medium and
BAPTA, respectively, p.0.05). Scalebar 5 mM.
doi:10.1371/journal.pone.0023097.g002
fragmentation of large clusters) after 1 h of treatment (12.464 clusters per 10 mm of dendrite length at baseline vs 15.363.7 at 1 h), followed by a
sharp decrease in GKAP cluster density (6.464.3 and 5.261.1 at 6 and 24 h, respectively; the percentage of synaptophysin puncta not matched by
GKAP-positive puncta was also reduced (to 80.565.7%, 57.3610.1% and 36.265.4%) by treatment with Ab42 after 1, 6 and 24 h, respectively. (I) Ab
induces the down-regulation of GKAP protein levels. Rat frontal cortical neurons were treated with Ab 1 mM for 0.5, 1, 3, 6 or 24 h and GKAP levels
were measured by immunoblot of whole cell lysates. Significant decrease was observed at 1 h (82.3614.3%, p,0.05) and at 3, 6, and 24 h timepoints
(69.3614.2%; and 48.4621.3% 50.3614.3% respectively, p,0.05). (K,L) Rat frontal neurons were treated with Ab (1 mM) for 15, 30, 45 or 60 min
before fixation and immunostaining for GKAP and synaptophysin. Ab did not affect GKAP cluster size after 15 and 30 min of treatment (97.5610.3%
and 93.3610.4%, both p.0.05), but significantly decreased GKAP cluster size at 45 and 60 min timepoints (81.469.5% and 68.668.5%, p,0.05). (M,N)
Changes in PSD ultrastructure are detectable between 30 and 60 minutes after Ab exposure. PSD was identified in EM images as an electron-dense
band in the post-synaptic terminal (arrows). A minimum number of 50 synapses out of three replicates per condition was assessed. PSD thickness was
comparable at baseline and after 30 min of treatment (3764 nm and 3564 nm), but was significantly reduced at 60 min (2763 nm, p,0.05). Scale
bar 200 nm.
doi:10.1371/journal.pone.0023097.g001
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PLoS ONE | www.plosone.org 4 July 2011 | Volume 6 | Issue 7 | e23097lanes 3 and 4). Taken together, these findings establish the
involvement of cdk5 in Ab-induced GKAP degradation.
Previously, cdk5 was shown to phosphorylate PSD95, whose
degradation after Ab treatment requires phosphorylation by cdk5
[13,31]. Therefore, to examine whether Ab-induced GKAP
degradation is directly or indirectly regulated by cdk5, frontocor-
tical neurons were transfected with GKAP-GFP together with wild
type PSD95 or a mutated form of PSD95 (PSD-AAA) whose cdk5
phospho-acceptor sites were replaced by alanine residues [31].
Like neurons overexpressing wildtype PSD-95, those expressing
PSD-AAA displayed GKAP clusters that were significantly larger
than those found in control (b-Gal-transfected) neurons (Fig. 4E,F).
However, application of Ab led to a comparable decrease in
GKAP cluster size in neurons expressing either wildtype PSD95 or
PSD-AAA (Fig. 4E,F), indicating that while both constructs increase
synaptic recruitment of GKAP, Ab-induced loss of GKAP occurs
independently of PSD-95 phosphorylation. Supporting the view
that GKAP degradation can be dissociated from PSD95
degradation, depletion of synaptic PSD95 with 2-bromopalmitate,
an inhibitor of palmitoylation [40], did not influence the ability of
Ab to downregulate GKAP (Fig. 4E,F).
Cdk5 interacts with GKAP and regulates GKAP
phosphorylation at specific sites
Since cdk5 plays an important role in the degradation of
GKAP, we were prompted to ask whether GKAP is a direct target
of this kinase, as suggested by the in silico identification of at least
two putative phosphorylation sites (Table S1). Cdk5 and GKAP
were found to colocalize extensively within synaptic sites of mature
neurons (87.464.5% of GKAP clusters were cdk-5 positive,
Fig. 5A). Moreover, cdk5 and GKAP could be co-immunopre-
cipitated from Triton X-100-solubilized cortical synaptosomes
(Fig. 5B); supporting a transient interaction between cdk5 and its
substrate, cdk5 could not be co-immunoprecipitated when a
stronger detergent (deoxycholate/NP40) was used. Further
evidence for direct interaction between GKAP and cdk5 was
provided by expressing GFP-tagged GKAP together with HA-
tagged cdk5 or myc-tagged p35 in SK-N-MC neuroblastoma cells.
Antibodies directed against the HA or myc epitopes allowed
pulling down of GKAP-GFP, and in a reverse experiment, anti-
GKAP immunoprecipitates were enriched in cdk-5-HA or p35-
Myc (Fig. 5C). We then verified Ab-induced GKAP phosphory-
lation in cortical neurons by probing immunoprecipitated GKAP
Figure 3. CaMKII regulates GKAP clustering, but does not prevent Ab-induced GKAP degradation. (A) Rat frontal neurons in culture were
pretreated with the cell-permeable peptidic inhibitors of CaMKII Autocamtide (2 mM) and CaMKII Inhibitor-I (1 mM) before exposure to Ab (1 mM, 1 h).
Both CaMKII Inhibitor-I and Autocamtide alone decreased GKAP cluster size (64.168.3% and 66.565.7% of baseline, respectively) but did not prevent
a further decrease after Ab treatment (67.468.3% CaMKII inhib+Ab vs CaMKII alone; 76.466.6% Autocamtide+Ab vs Autocamtide alone). (B) CaMKII
activation does not prevent Ab-induced GKAP degradation. Rat frontal neurons were transfected with GKAP-GFP together with either b-gal (negative
control) or with the constitutively active mutant of CaMKII (T286D). The mutant CaMKII increased the size of GKAP clusters (142.469.6% of b-gal-
expressing neurons), but did not prevent the loss of synaptic GKAP after Ab treatment (72.867.0%, CaMKII T286D+Ab vs CaMKII T286D alone). Scale
bar 5 mm.
doi:10.1371/journal.pone.0023097.g003
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PLoS ONE | www.plosone.org 5 July 2011 | Volume 6 | Issue 7 | e23097Figure 4. Cdk5 activity is required for Ab-induced GKAP down-regulation. (A) Roscovitine prevents GKAP degradation. Rat-cultured neurons
were pretreated with Cdk5 inhibitor Roscovitine (10 mM) or PNU 11, p38 kinase inhibitor (SB2035, 20 mM), before exposure to Ab. Roscovitine and
PNU11 effectively prevented GKAP down-regulation (103.7611.4% Rosco+Ab vs Rosco alone; 111.768.6% PNU11+Ab vs PNU alone, both p.0.05)
whereas SB2035 partially effective (71.867.3 SB+Ab vs SB alone, p,0.05). (B) Expression of cdk5-dominant negative prevents Ab-induced GKAP
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PLoS ONE | www.plosone.org 6 July 2011 | Volume 6 | Issue 7 | e23097with a phospho-Serine-specific antibody. As shown in Fig. 4D, Ab
treatment markedly increased overall phosphorylation levels of
GKAP (lanes 1 and 3), but GKAP phosphorylation was greatly
reduced by roscovitine (Fig. 5D).
In silico analysis predicted at least two cdk5 consensus sites
within the GKAP sequence located in the N-terminus of GKAP
(SP motifs at S77 and S111 in the GKAP sequence, corresponding
to S403 and S437 in the full-length SAPAP1 isoform, Fig. S4). To
establish the role of these two SP motifs as targets of cdk5 we
mutated both serines to alanine residues (GKAP S77/111A,
hereinafter named GKAP-AA). Since in vitro kinase assays may
inherently suffer from specificity, we co-expressed GKAP-GFP-WT
and GKAP-GFP-AA together with cdk5 and p35 (or b-Gal as control)
in SK-N-MC cells; GKAP was then immunoprecipitated and a
phospho-Serine antibody was used as probe. While overexpression
of cdk5/p35 resulted in markedly increased phosphorylation of
GKAP-GFP-WT (further supporting the role of cdk5 in
phosphorylating GKAP), the phosphorylation status of the
GKAP-AA double mutant was unchanged (Fig. 5E). Furthermore,
in SK-N-MC cells (which express endogenous NMDAR, p35 and
cdk5 expression, [13]) transfected with GKAP-GFP-WT, treat-
ment with Ab resulted in a significant decrease in GKAP protein
levels in whole cell extract, whereas GKAP-GFP-AA proved
resistant to the effects of Ab (Fig. 5F).
GKAP-AA mutant is resistant to degradation and
prevents Ab-induced actin remodeling in synapses
To confirm the role of cdk5 and of the two putative
phosphorylation sites in Ab-induced GKAP degradation, we
transfected mature primary neurons with GKAP-GFP-WT or AA.
When expressed in cortical neurons, both GKAP-GFP-WT and
GKAP-GFP-AA displayed a punctuate distribution along den-
drites (Fig. 6A,B) and the clusters of both WT and mutant protein
colocalized with synaptophysin puncta (Fig. 6B). Notably, cluster
size distribution of GKAP-GFP-AA was significantly rightward
shifted (i.e. toward larger clusters) compared with the WT protein
(not shown). Application of Ab to cortical neurons that had been
transiently transfected with either GKAP-GFP-WT, double-mutat-
ed GKAP-AA or the single-mutated GKAP-S77A or GKAP-S111A,
resulted in a major decrease in GKAP cluster size in GKAP-WT-
expressing cells (64.4611.5% of control, p,0.05), whereas the
changes in GKAP levels were smaller in cells expressing the S77A
(88.6610.7%) and S111A (74.866.9%) mutations and absent in
cells transfected with GKAP-AA (108.069.1%) (Fig. 6C,D). Taken
together, these sets of data suggest that Ab triggers the
phosphorylation of GKAP by cdk5 at the serine residues S77
and S111 that in turn are crucial for GKAP degradation.
Previous work identified the remodeling of actin structures
among the synaptic effects of Ab [10]. Since GKAP and other
SAPAP family members interact with actin-regulating proteins
such as nArgBP2, Shank and pyk2 [25,41,42] we investigated
whether GKAP loss impacted on Ab-induced modifications of the
actin cytoskeleton. Under baseline conditions, tranfected cortical
neurons displayed extensive colocalization of actin-RFP with
exogenously expressed GKAP-GFP-WT and GKAP-GFP-AA
(Fig. 6E,F). Treatment of neurons with Ab resulted in marked
reductions in GKAP-WT-GFP (54.5611.3%, p,0.05) and actin-
RFP (61.364.5% of control, Fig. 6E,F) cluster sizes. When the
same treatment was applied to neurons transfected with GKAP-
AA-GFP, no marked changes in either GKAP-AA-GFP
(92.3614.6, p,0.05; Fig. 6E,F) or actin-RFP (94.7613.9% of
control, p.0.05, Fig. 6E,F) cluster sizes were observed. Notably,
GKAP-GFP-AA-expressing neurons displayed an increase in
elongated spines with split head and sporadically abnormally
large actin clusters colocalized with GKAP-GFP-AA clusters were
detected.
Thus, preventing cdk-5 phosphorylation of GKAP (by express-
ing the GKAP-AA mutant) prevents Ab effect on actin
cytoskeleton. To confirm the involvement of cdk5 in Ab-induced
actin remodeling, cortical neurons were transfected with actin-
RFP (or with the F-actin sensor Lifeact-Ruby, [43]) and pretreated
with roscovitine before exposure to Ab (1 mM, 1 h). Whereas Ab
markedly decreased actin cluster size (67.1613.3% of baseline,
Fig. 6G), roscovitine pretreatment largely abolished this effect
(90.9615.1% of control; Fig. 6G). These findings were confirmed
in neurons expressing the F-actin sensor Lifeact Ruby (Fig. 6G).
Discussion
The principal findings of the present work are that exposure to
Ab results in the removal and degradation of synaptic GKAP, the
latter being a consequence of cdk5 activity and phosphorylation of
two consensus sites in the N-terminus of the protein.
The AD brain accumulates the 40 and 42 amino acid forms of
Ab peptide, the latter being the principal component of amyloid
fibrils and plaques [44]. In contrast, Ab40 peptide is highly
represented in the soluble amyloid fraction [44] and its levels
degradation. Rat frontal neurons were co-transfected at DIV5 with GKAP-GFP together with b-galactosidase (as negative control), cdk5-WT, p35-WT,
cdk5-DN or sh-Cdk5 and were exposed to Ab (1 mM, 1 h) or vehicle at DIV9. In neurons overexpressing cdk5 or p35 GKAP cluster size was decreased
at baseline (87.463.5% and 67.566.6% vs GKAP+b-Gal respectively, p,0.05) and was further decreased by Ab (57.168.2% and 54.763.8% after Ab in
neurons overexpressing cdk5 and p35, respectively, p,0.05). On the other hand, in neurons expressing GKAP together with cdk-dominant negative
or sh-cdk5, GKAP were significantly larger than in b-gal expressing neurons (159.4620.2% and 137.369.5% of baseline, respectively, p,0.05) and
GKAP degradation was completely prevented (100.0611.3%, cdk5-DN+Ab vs cdk5-DN alone; 99.062.2% shCdk5+Ab vs shCdk5 alone, p.0.05). (C)
Roscovitine prevents GKAP degradation in whole cell protein extract. Rat frontal neurons in culture were pretreated with roscovitine, SB2035 or
vehicle before Ab treatment (1 mM, 1 h). Neurons were lysed and GKAP levels were assessed by western blot. Roscovitine completely prevented GKAP
degradation (108.8620.6%, Rosco+Ab vs Rosco alone, p.0.05, as compared with 50.8611.1% vehicle+Ab vs Ab alone, p,0.05) whereas SB2035 was
infective (49.5613.6%, SB+Ab vs SB alone, p,0.05). (D)A b causes the ubiquitination of GKAP in a cdk-5 dependent manner. Rat frontal cortical
neurons were pretreated with MG132, with or without roscovitine, before being exposed to Ab (1 mM, 1 h). GKAP was immunoprecipitated from
whole cell lysate and the blots probed with anti-polyubiquitin antibody. Ab treatment caused the marked increase in GKAP ubiquitination (lane 2)
with an increase in polyubiquitin smear. Roscovitine reduced GKAP ubiqutination in basal conditions (lane 3) and greatly decreased Ab-induced
ubiquitination of GKAP (lane 4). (E,F)A b-induced GKAP down-regulation is independent of PSD-95 degradation. Rat frontal neurons were transfected
with GKAP-GFP-WT together with either b-Galactosidase (b-Gal, negative control) or PSD-95-WT or PSD-95-AAA at DIV5–6 and treated with Ab (1 mM,
1 h) at DiV9. Overexpression of PSD-95 WT and PSD-AAA alone caused the increase in GKAP-GFP cluster size (158.2612.3% and 202.4632.5% of
GKAP-GFP/bGal, respectively); Ab treatment determines a significant decrease in GKAP-GFP cluster size (75.665.7% PSD-95WT/GKAP-GFP+Ab vs PSD-
95WT/GKAP-GFP alone; 66.869.9% PSD-95-AAA/GKAP-GFP+Ab vs PSD-95-AAA/GKAP-GFP alone, all p,0.05). In a parallel set of experiments, neurons
expressing GKAP-GFP/b-Gal were pretreated for 8 h with 2-bromopalmitate (10 mM) before exposure to Ab (1 mM, 1 h). Baseline GKAP cluster size
was not significantly reduced (94.4613.4% of untreated controls, p.0.05) and Ab effect was not prevented (70.167.0% 2-BP+Ab vs 2BP alone,
p,0.05). Imaging parameters were kept constant across conditions, scale bar 5 mm.
doi:10.1371/journal.pone.0023097.g004
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patients [44,45]. Imprtantly, while Ab42 is prone to form
aggregates, Ab40 stably assembles into low-n oligomers [46] and
is considered responsible for memory and synaptic dysfunction
[47,48]. Given these facts, the Ab40 peptide was used in these
studies to study Ab-associated neurotoxiciry without the con-
founding effects of high-molecular weight aggregates.
Ab peptides exert a profound effect on synaptic structures
[11,49,50]. Prominent among these effects are the degradation and
loss of a number of PSD proteins [7,10,13], effects that lead to the
collapse of synapses. PSD-95 is a major constituent of the PSD,
participating in the trafficking and signaling of glutamatergic
receptors [16]. Levels of PSD-95 are down-regulated by Ab,b o t h
in vivo [45] and in vitro [13]),and the loss ofPSD-95 correlates with the
removal of AMPAreceptors [13]. Ab-induced degradation of PSD95
is dependent upon NMDAR activity and phosphorylation by cdk5 at
three serine residues located in the N-terminal domain, whose
replacement by alanine protects PSD-95 from Ab-induced protea-
somal degradation [13,31]. The results of the present study show that
GKAP is also regulated by cdk5 after NMDAR activation.
The involvement of NMDAR in Ab-induced disassembly of the
PSD adds to the growing spectrum of effects of Ab that depend on
Figure 5. Degradation of GKAP after Ab treatment is mediated by cdk-5-dependent phosphorylation of two epitopes at S77 and
S111. (A) GKAP and cdk5 colocalize in synaptic sites. Rat frontal neurons were immunostained for GKAP and cdk5; in dendrites, both proteins
displayed a punctuate staining with very high colocalization (95.4% of GKAP-positive puncta were cdk5-positive). (B) GKAP immunoprecipitated from
cortical synaptosomes was detected with an anti cdk5 antibody (with significant quantity of cdk5 identified); no signal was visualized upon blotting
with anti-synapsin antibody. (C) SK-N-MC cells were transfected with either GKAP-GFP and p35-HA or with GKAP-GFP and cdk5-myc.
Immunoprecipitation of GKAP efficiently co-purified both p35 (detected by anti-HA antibody) and cdk5 (detected by anti-myc antibody); in the
reverse order of the experiment immunoprecipitation with anti-HA and anti-myc antisera efficiently enriched for GKAP-GFP. (D) GKAP
phosphorylation is increased by Ab in a cdk-5-dependent manner. Rat frontal cortical neurons were treated with Ab 1 mM for 30 min with or
without pretreatment with roscovitine. GKAP was immunoprecipitated and probed with an anti-phosphoserine antibody mix. Ab treatment caused a
marked increase in GKAP phosphorylation (384.2621.5% of baseline, p,0.05, lanes 1 and 3), but this effect was greatly reduced by roscovitine
(173.8628.1%, lane 2). (E) GKAP-S77/111A (GKAP-AA) escapes from cdk5 phosphorylation. SK-N-MC cells were transfected with either GKAP-GFP-
WT+bGal (negative control), or with GKAP-GFP-WT+p35+cdk5 or with GKAP-GFP-AA+p35+cdk5/as depicted. GKAP WT or the mutated form were
immunoprecipitated with an antibody against GFP and tested with an antibody against phospho-serine. Co-transfection with cdk5/p35 greatly
increased the phosphorylation of GKAP-WT compared to baseline (lane 1 and 2), but did not increase the phosphorylation of GKAP-AA (lane 3). (F)
GKAP-AA resists Ab-induced degradation. SK-N-MC cells were transfected with either GKAP-WT or GKAP-AA and treated with Ab (1 mM, 1 h) or
vehicle. Ab caused a decrease of GKAP-WT levels by 46.468.8% (p,0.05) of control, whereas GKAP-AA levels were not affected by Ab (99.864.4%,
GKAP-AA+Ab vs GKAP-AA alone, p.0.05).
doi:10.1371/journal.pone.0023097.g005
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PLoS ONE | www.plosone.org 8 July 2011 | Volume 6 | Issue 7 | e23097Figure 6. Blockade of GKAP degradation prevents Ab-induced actin cytoskeleton remodeling. (A,B) GKAP-AA is localized in synapses. Rat
frontal neurons were transfected with either GKAP-WT or GKAP-AA, fixed and immunostained for synapsin-I. Synapsin-I clusters opposed to the
majority of GKAP clusters, confirming the proper trafficking of the mutated form of GKAP. (C,D) GKAP-AA is resistant to Ab-induced degradation in
dendritic spines. Rat frontal cortical neurons were transfected with either GKAP-WT-GFP or with the single point mutation GKAP-S77A-GFP and GKAP-
S111A-GFP or with the double point mutation GKAP-AA. Upon Ab treatment, GKAP-WT cluster size decreased to 64.4611.5% (p,0.05) of vehicle-
treated control. Cluster size for GKAP-S77A-GFP and GKAP-S111A-GFP decreased to 88.6610.7% and 74.866.9% of vehicle-treated, respectively
(p,0.05); GKAP-AA clusters were completely resistant to Ab-induced down-regulation (108.069.1% of vehicle-treated, p.0.05). Scale bar 5 mm. (E,F)
Rat frontal cortical neurons were transfected at DIV5–6 with Actin-RFP together with either GKAP-WT-GFP or GKAP-AA-GFP and treated with Ab
(1 mM, 1 h) at DIV 9–10. In control conditions (A), GKAP-GFP and Acti-RFP were highly colocalized and both were enriched in dendritic spines. Upon
Ab treatment, both GKAP-WT-GFP and Actin RFP cluster size decreased (for actin, 61.364.5% of control, p,0.05). In GKAP-AA-expressing neurons,
actin-RFP cluster size was not affected by Ab (94.7613.9%, GKAP-AA+Ab vs GKAP-AA alone, p.0.05). However, abnormal clusters of GKAP-AA and
actin could be seen (panel B, arrow). (G) Roscovitine prevents Ab-induced actin remodeling. Rat cortical neurons were transfected with actin-RFP and
pretreated with roscovitine (10 mM) or vehicle before being exposed to Ab (1 mm, 1 h). In vehicle-pretreated neurons Ab decreased actin-RFP cluster
size by 67.1613.3% (p,0.05); on the other hand, roscovitine completely blocked Ab effect (90.9615.1% of control, p.0.05). Likewise, Ab caused a
marked decrease in F-actin accumulation in spines (61.566.7% of control, p,0.05), whereas roscovitine pre-treatment largely blocked this effect
(90.0615.1%, Rosco+Ab vs Ab alone). Scale bar 5 mm.
doi:10.1371/journal.pone.0023097.g006
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glutamate receptor is required for synaptic targeting of Ab
oligomers [51] and that NMDAR activity is required for Ab-
induced blockade of axonal transport and triggering of oxidative
stress as well as mitochondrial fragmentation and changes in spine
morphology [52–54]. These findings suggest that NMDAR
constitute the first hub in Ab signaling cascades.
The present work identifies cdk5 as a major downstream
cascade of NMDAR signalling. Moroever, it establishes GKAP as
bona fide cdk5 substrate since i) cdk5 and GKAP interact
physically; ii) overexpression of cdk5 increases GKAP phosphor-
ylation; iii) blockade of cdk5 substantially reduces GKAP
phosphorylation; and iv) mutation of the cdk5 consensus sites on
GKAP prevents GKAP phosphorylation. As in the case of PSD-
95, Ab-induced phosphorylation of GKAP leads to proteasomal
degradation, and phosphorylation-resistant mutants of both
proteins fail to undergo degradation after Ab treatment.
Importantly, however, the final steps of their degradation diverge
beyond cdk5: PSD-95 is ubiquitinated by mdm-2 [28], whereas
GKAP becomes a substrate for TRIM3 [55]. Further, GKAP
degradation occurs even in neurons expressing a degradation-
mutant of PSD-95 (Fig. 3E,F), indicating that GKAP and PSD-95
can occur independently of each other. Since a number of
membrane-associated guanylate kinase (MAGUK) scaffold pro-
teins such as PSD-93, PSD-95, SAP102 and CASK [31,56] carry
N-terminal cdk5 consensus sites, it appears that cdk5 is part of a
regulatory pathway common to MAGUKs (and, potentially, to
other non-GUK proteins, e.g. SPAR; [57]). The wide represen-
tation of cdk5 consensus sites in scaffold proteins suggests that cdk5
has a ‘gatekeeper’ role in PSD assembly/disassembly, notwith-
standing minor contributions by other kinases (e.g. CaMKII, see
[39]; potentially p38k, see [58]). The findings reported here bolster
the view that cdk5 plays a critical role in AD; previous work
showed its importance in mediating Ab-induced synaptic dysfunc-
tion [59] and PSD protein degradation [13,17] as well as in tau
hyperphosphorylation, transcriptional derangement, amyloidogen-
esis and neuronal apoptosis [60–63]. While cdk5 appears to be
central in Ab-induced degradation of PSD-95 and GKAP [13,17
and results presented here], other Ab effects, such as NMDAR and
Insulin receptors [64], are dependent upon CaMKII activity.
However, our experiments reveal that CaMKII is not involved in
GKAP degradation. Taken together, these findings underscore the
divergence of signalling cascades that are initiated by Ab and the
segregation of their synaptic effects.
Derangement of the actin cytoskeleton of synapses is likely to be
a crucial step in Ab-triggered synapse demise [11,10]; to date, at
least one pathway involving LIM kinase inactivation, calcineurin
activation and dephosphorylation of the actin-depolymerizing
factor cofillin has been implicated in this process [11,15].
However, since GKAP interacts with several proteins involved in
actin regulation (e.g. nArgBP2, Shank and pyk2; [19,25,41]) and
since blockade of GKAP degradation results in increased dendritic
spine size [55], it is plausible that GKAP loss may be, at least
partly, responsible for the actin derangement observed after Ab
treatment [10]. Supporting this notion, we found that expression
of phosphorylation-resistant GKAP or treatment with cdk-5
inhibitors counteracts Ab-induced actin depolymerization. The
finding that GKAP degradation contributes to the collapse of actin
structures [10], strengthens the view that GKAP is important for
maintaining the organization of the actin cytoskeleton in dendritic
spines. In fact, cdk5 and its activators can associate with actin
structures [65,66] and several actin-regulating proteins (e.g.
WAVE, ephexin-1 and spinophillin) are known cdk5 substrates
[67–69]. Moreover, cdk5 has been shown to act as a negative
regulator of the actin cytoskeleton, and phospho-WAVE and -
ephexin-1 prevent actin polymerization [68,69], induce the
collapse of actin structures, and cause dendritic spine retraction
[70]. Extrapolating from these various findings, it would appear
that cdk-5-mediated GKAP degradation disconnects the actin
structures from the PSD and/or influence the localization of actin-
regulatory proteins; in the context of the present work, GKAP loss
is likely to occupy a central position in the cascade leading from
PSD disassembly to Ab-triggered collapse of the synaptic actin
cytoskeleton.
Materials and Methods
Ethic Statement
The study was approved by the Government of Upper Bavaria
(Regierung von Oberbayern, Muenchen) Animal welfare commit-
tee (authorization number 55.2-1-54-2531-169-09) and conformed
international (EU Directive 86/609) standards on animal welfare
and experimentation. All possible steps were taken toward
reducing the number of animals used and their suffering.
Drugs and chemicals
Ab1–40 (American Peptides, Sunnyvale, CA) was prepared as
previously described [13] to yield predominantly low N-oligomers
(mainly monomeric to tri-tetrameric, see Fig. S1) [71–73] rather
than Ab fibrils [74,75]. Ab1–42 (Bachem, Bubendorf, CH) was
resuspended in Hexafluoro-2-propanol (HFIP)and soluble oligo-
mers were prepared according to [64]. Briefly, the peptide was
dissolved in HFIP to 1 mM and stored as a dried film at 280uC
after solvent evaporation. The film was resuspended in DMSO to
a final concentration of 5 mM, thoroughly vortexed and sonicated
for 10 min. The solution was then diluted with ice-cold neurobasal
medium to 100 mM and stored at 4uC (16 h). The solution was
centrifuged at 14,000 g (10 min) and the supernatant was used for
treatment.
Roscovitine, (6)-verapamil, BAPTA-AM, 2-bromo palmitate
(2-BP) and cycloheximide were purchased from Sigma Chemicals
(Deisenhofen, Germany); MK801 (5S,10R)-(+)-5-Methyl-10,11-
dihydro-5H-dibenzo[a,d]cycloheptene-5,10-imine maleate, ifen-
prodil (1R*,2S*)-erythro-2-(4-Benzylpiperidino)-1-(4-hydroxyphe-
nyl)-1-propanol hemitartrate, NBQX (2,3-Dioxo-6-nitro-1,2,3,4-
tetrahydrobenzo[f]quinoxaline-7-sulfonamide), UO126 (1,4-Di-
amino-2,3-dicyano-1,4-bis[2-aminophenylthio]butadiene), wort-
mannin, lactacystin, AEG3482 (6-Phenylimidazo[2,1-b]-1,3,4-
thiadiazole-2-sulfonamide, inhibitor of JNK signaling) and
SB2035 (fluorophenyl)-2-[4-(methylsulfonyl)phenyl]-1H-imidazol-
4-yl]pyridine, p38 kinase inhibitor) were from Tocris (Bristol, UK);
6-Aminopyridine-sulfonamide (PNU112455A; cdk2/5 inhibitor),
sodium orthovanadate, SU6656 (2,3-dihydro-N,N-dimethyl-2-
oxo-3-[(4,5,6,7-tetrahydro-1H-indol-2-yl)methylene]-1H-indole-5-
sulfonamide) and MG132 (z-Leu-Leu-Leu-al proteasome inhibi-
tor) were from Calbiochem (La Jolla, CA).
Antibodies
Rabbit polyclonal anti-GKAP antibody was kindly provided by
M. Sheng (Cambridge, MA) or purchased (Cat. No. H81) from
Santa Cruz Biotechnology (Heidelberg, Germany); anti-myc and
anti-HA antisera were also from Santa Cruz. Mouse monoclonal
anti-synaptophysin was purchased from Sigma, rabbit polyclonal
anti-synapsin I from Chemicon (Temecula, CA), anti-p35, -cdk5,
from Cell Signalling (Frankfurt am Main, Germany), anti-
phospho-serine mix from Qiagen (Hilden, Germany), anti-
polyubiquitin from Beckton Dickinson (Erembodegem, Belgium),
and mouse monoclonal anti-GFP from NeuroMab (Davis, CA).
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Trypsin-dissociated primary cell cultures were prepared from
frontal cortical tissue from 4-day-old (P4) Wistar rats (Charles
River, Sulzfeld, Germany), as described previously [17]. Cells were
plated onto gelatin/PDL-coated 6-well plates at a density of 450–
500 cells/mm
2 or on glass coverslips (450 cells/mm
2 for
immunostaining and -blotting experiments; 800 cells/mm
2 for
transfection studies). Experiments were started after 10–13 days in
vitro (DIV 10–13). Studies under Ca
2+-free conditions were
performed by incubating cells in artificial cerebrospinal fluid
(NaCl 124 mM, KCl 3 mM, NaHCO3 26 mM, MgSO4 1 mM,
KH2PO4 1.25 mM, glucose 10 mM) for 30 min before treatment.
Likewise, drugs were added to the culture medium 30 min before
Ab treatment.
Culture of SK-N-MC cell line
Human neuroblastoma SK-N-MC (obtained from ATCC, Cat.
No. HTB-10) cells were maintained at 37uC (5% CO2/95% air) in
DMEM supplemented with 10% FCS (Invitrogen, Darmstadt,
Germany) and 1% kanamycin. Cells were seeded on 100 mm Petri
dishes (2610
6 cells) or 6-well plates (10
5 cells) 24 h before use.
Brain fractionation and synaptosome preparation
Synaptosomes were prepared using a previously described
method [76]. Briefly, cerebral cortices were dissected out on ice,
homogenized in 10 volumes of ice-cold buffer (sucrose 0.32 M and
HEPES 5 mM) containing protease (Complete Protease Inhibitor;
Roche, Mannheim, Germany) and phosphatase (Phosphatase
Inhibitor Cocktails I and II; Sigma) inhibitor cocktails, before
centrifugation (1000 g, 5 min). The resulting supernatant was
centrifuged at 15000 g (15 min); the resulting pellet re-suspended
in sucrose buffer (0.3 M) and centrifuged (15000 g, 15 min.) to
yield a crude synaptosomal preparation.
Plasmids and targeted mutagenesis
The GW1-CMV-GKAP-GFP construct was a gift of C. Sala
(Milan, Italy). Constructs encoding p35-myc, cdk5-HA and cdk5-
DN-HA were obtained from Addgene (Cambridge, MA; plasmids
1347, 1872, and 1873, respectively). An RNAi against cdk5 in
pSilencer2.0 was kindly provided by L.H. Tsai (Cambridge, MA;
see [56]). Wild-type PSD-95 and triple alanine (T19A, S25A,
S35A) point-mutated PSD-95 were kindly provided by M.
Morabito (Worcester, MA) and were previously described [31].
The constructs encoding farnesylated-EGFP and constitutively
active CaMKII (T286D) were gifts from M. Zagrebelsky
(Braunschweig, Germany) and G. Turrigiano (Waltham, MA),
respectively. Plasmids encoding actin-RFP and Lifeact-Ruby were
provided by D. Refojo (Munich, Germany) and R. Wedlich-
Soldner (Martinsried, Germany).
Site-directed mutagenesis of GKAP was performed according to
[77] with slight modifications. PCR products were purified on
PCR clean-up spin columns (Macherey-Nagel, Dueren, Germany)
and the DNA was digested with DpnI (20 U) for 90 min at 37uC,
after which Dpn1 was inactivated (65uC, 10 min). DNA was
extracted (phenol/chloroform), precipitated and inoculated into
transformed, electro-competent bacteria (Invitrogen). Site-directed
mutations were confirmed by sequencing.
Transfection
Neuronal cultures were transfected with a total of 1–1.2 mg
DNA per well, using Lipofectamine 2000, following the manufac-
turer’s protocol (Invitrogen). Neurons were transfected at DIV 5–6
and used at DIV 9–11. SK-N-MC cells (70% confluence) were
transfected using Jet-PEI (Polytransfection, Illkirch, France)
following a previously published protocol [78], using 6 mgo r1 –
1.2 mg DNA, respectively, when 100 mm plates or 6-well dishes
were used. SK-N-MC cells were replenished with fresh medium
16 h after transfection and harvested after 24 h.
Immunocytochemistry and image analysis
For immunolocalization experiments, neurons grown on coated
glass coverslips were fixed in cold methanol (220uC, 20 min),
blocked (5% BSA and 0.001% Triton X-100 in PBS) and
incubated with anti-GKAP (1:1000), anti-synaptophysin (1:500) or
anti- cdk-5 (1:500) at 4uC (18 h). Following extensive washing,
coverslips were incubated (1 h, RT) with secondary anti-mouse
(conjugated with Alexa-594, Invitrogen) or anti-rabbit (conjugated
with Alexa-488, Invitrogen) before washing and mounting.
Transfected neurons were fixed in freshly prepared 4% PFA in
PBS (4 min, RT) before mounting. Images were captured with an
Olympus FluoView1000 confocal microscope using a plan-
apochromat 636/1.2 water lens, at a resolution of 102461024.
GKAP cluster size was analyzed using ImageJ software after
thresholding at the arbitrary value of 150. Only GKAP clusters
justaxposed to synaptophysin puncta (manually selected by an
investigator who was blind to the treatments) were evaluated;
surface areas were measured with ImageJ software and logged into
an Excel file. Clusters separated by 1 pixel were considered to
represent individual clusters. To reduce noise effects, only clusters
$3 pixels were included in the analysis; while this criterion
possibly introduced a bias toward smaller differences in treated vs.
untreated groups in cases where treatment caused a shrinkage of a
substantial proportion of clusters to ,3 pixels, it would rather lead
to an overestimation of average cluster size in the treated groups
without undermining the statistical significance of detected
differences. The cluster size analysis was complemented by
independent evaluation of the images by a second investigator
(also blind to treatments) who ranked images according to cluster
size; in all cases, there was a 100% match between these latter
qualitative evaluations and the quantitative analysis. Co-localiza-
tion was defined as the number of puncta displaying immunopo-
sitive synaptophysin and GKAP puncta/total number of synapto-
physin-positive puncta. Only puncta $3 pixels were considered to
be clusters and included in the analysis. The same procedure was
adopted for GKAP-GFP clusters in transfected neurons, except
that the arbitrary threshold was set at 210. For estimating the
spine/shaft intensity ratio, a fixed-size circular region of interest
was placed on the spine head on the underlying dendrite (and in
the nearby empty space for background measurements which was
then subtracted).
Electron microscopy
Primary neurons were grown on Permanox slides (LabTek,
Nalgene, Naperville IL) at 600 cells/mm
2 and used after 13 DIV.
After treatment, cell monolayers were washed in PBS, fixed for
30 min. (25uC) in 3% PFA/3% glutaraldehyde/0.1 M cacodylate
buffer (Electron Microscopy Sciences, Hatfield, PA), post-fixed
(2% osmium tetroxide), dehydrated, embedded in Epon resin
(Electron Microscopy Sciences), and ultrathin sections (70 nm)
were prepared and collected on copper grids. Sections were
stained with 0.5% uranyl acetate and 3% lead citrate, and grids
were examined with an EM10 Zeiss electron microscope
(acceleration voltage: 60 kV). Images were acquired at 50,0006
original magnification and at resolution of 137661036 pixels.
Only artifact-free synapses, with clearly identifiable presynaptic
terminals, synaptic clefts, postsynaptic membranes and PSD were
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profiles for each PSD) were measured with ImageJ software.
Immunoprecipitation
Transfected SK-N-MC cells were lysed in modified RIPA buffer
(50 mM Tris-HCl, 120 mM NaCl, 1% NP-40, 0.5% deoxycho-
late, 5 mM MgCl2, 1 mM EDTA, plus protease and phosphatase
inhibitors); lysates were cleared by centrifugation (12000 g,
10 min), and 500 mg solubilized protein aliquots were incubated
(18 h) with anti-HA, anti-c-myc or anti-SAPAP1 (1 mg each).
Immunocomplexes were precipitated by incubation with 30 ml
Dynabeads (Invitrogen) for 1 h at 4uC, washed (2 times) in high-
salt buffer (50 mM Tris HCl, 500 mM NaCl, 0.1% NP-40, 0.05%
deoxycholate), and eluted in Laemmli buffer. Washed synapto-
somal fractions were re-dissolved in either modified RIPA buffer
(see above) or Triton X-100 buffer (10 mM Tris-HCl, 2% Triton
X-100, plus proteases and phosphatases inhibitors [56]. Triton-
solubilized fractions were cleared by centrifugation (12000 g,
10 min) and solubilized protein was incubated (18 h) with 2 mg
anti-GKAP. Immunocomplexes were precipitated by incubation
with protein G/protein A-Agarose mix (Invitrogen) and washed
twice with high-salt Triton buffer (100 mM NaCl, 0.2% Triton X-
100) before elution in Laemmli buffer.
Immunoblotting
Neurons were lysed by brief sonication in complete RIPA buffer
(50 mM Tris-HCl, 150 mM NaCl, 1 mM EDTA, 5 mM MgCl2,
1% NP-40, 0.1% SDS, 0.5% sodium deoxycholate, plus protease
phosphatase inhibitor cocktails), before clearing by centrifugation
(12000 g, 10 min). Cleared lysates (40 mg) were fractionated by
electrophoresis on 8% SDS-polyacrylamide (PAGE) gels and
transferred onto nitrocellulose membranes which were then
blocked (5% nonfat dryed milk powder and 0.2% Tween-20 in
PBS) and incubated with the following antibodies: anti-GKAP
(1:1000), anti-synapsin I (1:1000), anti-GFP (1:2000), and anti-
actin (1:10,000) or anti-b-tubulin (1:2000; Oncogene Sciences,
Uniondale, NY). Antigens were detected by enhanced chemilu-
minescence (GE Healthcare, Freiburg, Germany) after incubation
with appropriate horseradish peroxidase-IgG conjugates (GE
Healthcare); a mixture of anti-mouse IgG and anti-mouse IgM
was used in combination with primary anti-phospho-serine
antibody.
For amyloid oligomer detections, amyloid peptides were diluted
at 1 mM in Neurobasal medium, incubated for 1 h at 37u, loaded
in non/denaturing Tricine PAGE buffer (Tris 200 mM, 40%
Glycerol) and fractionated on a 4–15% acrylamide gradient in
100 mM Tris/100 mM Tricine/0.1% SDS buffer. The gel was
transferred on nitrocellulose membrane, blocked and incubated
with antibody against amyloid-b (1:1000, Cell Signaling). After
incubation with HRP-conjugated secondary antibody, the peptide
bands were revealed using SuperSignal Femto substrate (Pierce).
Blots were scanned and quantified using TINA 3.0 bioimaging
software (Raytest, Straubenhardt, Germany). Linearity was
routinely checked during semi-quantification of all blots. All
values were normalized and expressed as percentages of controls;
in pharmacological experiments, percentages were calculated as
Ab-treated vs Ab-untreated. Each set of depicted numerical data
was obtained from 3–5 independent sets of experiments, with 3
replicates in each run.
Statistics
All data are depicted as mean 6 SD (3–5 independent
experiments). Immunofluorescence data derive from evaluation
of a minimum of 600 synapses (N) in each of 8–10 neurons (n).
Data were analyzed for statistical significance using ANOVA and
appropriate post hoc tests (Student-Keuls or Kruskal-Wallis multiple
comparison procedures, as appropriate) where p,0.05 was set as
the minimum level of significance.
Supporting Information
Figure S1 Amyloid-b forms low-N oligomers in culture
medium. Amyloid-b 40 was diluted in the culture medium at the
concentration used to treat neurons and incubated at 37uC for 1 h.
Samples of incubated, diluted Ab were resolved on polyacrylamide
gradient gel under non-denaturating conditions and probed with
anti Ab antibody. Three prominent bands were detected, in the
range between 4 and 12 kDa, corresponding to monomers to
trimers of the peptide.
(TIF)
Figure S2 Ab effect on GKAP cluster size is dose-
dependent. Rat cortical neurons were treated with different
concentrations of Ab for 1 h before fixation and immunostaining;
GKAP cluster size was not affected by 10 nM Ab (103.369.0% of
baseline), but was dose-dependently reduced by treatment with
100 nM, 1 mM, 10 mMA b for 1 h (85.366.3%, 64.964.0% and
57.161.2%, respectively, p,0.05).
(TIF)
Figure S3 AMPAR, VDCC and tyrosine kinases are not
involved in GKAP down-regulation. (A) AMPAR and VDCC
are not involved in Ab-induced degradation of GKAP. Pretreat-
ment of rat cortical neurons with either the AMPAR blocker
NQBX (25 mM) or the VDCC blocker Verapamil (50 mM) before
exposure to Ab (1 mM, 1 h) did not prevent GKAP down-
regulation in synaptic clusters (53.866.3% and 54.466.0,
respectively, p,0.05). (B) Tyrosine kinases are not required for
Ab-induced down-regulation of GKAP. Rat cultured neurons
were pretreated with or with the src-family inhibitor SU6656
(10 mM) or with the tyrosine phosphatase inhibitor Na3VO4
(100 mM) before treatment with Ab (1 mM,1 h); neither compound
prevented Ab effects (63.768.5, SU+Ab vs SU alone, p.0.05;
70.9614.5, Na3VO4+Ab vs Na3VO4 alone, p.0.05).
(TIF)
Figure S4 Putative phosphorylation sites targeted by
cdk5 and CamKII. Phosphopeptide database (see Table S1) was
interrogated using the GKAP sequence; the resulting GKAP
phosphoepitopes were annotated using two kinase-target predic-
tion software (Scansite and Phosida).
(TIF)
Figure S5 Ab-induced GKAP degradation does not
require PI-3K, ERK, Jnk and PKC activity, but depends
on proteasome activity. (A) Rat frontal neurons were
pretreated with PI-3K inhibitor Wortmannin (2 mM), ERK
inhibitor UO126 (10 mM), Jnk inhibitor (AEG 100 mM) or PKC
inhibitor Go ¨6893 (5 mM) before being exposed to Ab (1 mM, 1 h).
All inhibitors were ineffective (51.568.1 Wort+Ab vs Wort alone,
p,0.05; 59.669.2 UO+Ab vs UO alone, p,0.05; 61.767.2
AEG+Ab vs AEG alone, p,0.05; 67.365.5 Go ¨+Ab vs Go ¨ alone,
p,0.05). (B) Rat frontal cortical neurons were treated with Ab
(1 mM) for 0.5, 1, 3, 6 or 24 h. The levels of cdk5 and of the cdk5
activator p35 and the truncated p25 were assessed in whole-cell
lysate. Cdk5 levels were not significantly affected by Ab
(111.3611.4%, 122.2633.0%, 110.4623.1%, 109.2632.3%,
109.469.4% at 0.5, 1, 3, 6, and 24 h timepoints, respectively;
p.0.05), whereas p35 levels were significantly increased, peaking
at 3 h (135.2616.0%, 216.4618.9%, 247.8649%, 176.367.2%,
0.8660.42% at 0.5, 1, 3, 6, and 24 h timepoints) (C)A b-induced
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neurons were pretreated with the proteasome inhibitors MG132
(1 mM) or lactacysthine (10 mM) or the lysosome pathway blocker
chloroquine (100 mM) before being exposed to Ab (1 mM, 1 h). Ab
effect on GKAP cluster size was completely prevented by MG132
and lactacysthine treatment (107.568.3% MG+Ab vs MG alone,
p.0.05; 109.367.4%; lacta+Ab vs lacta alone, p.0.05) whereas
chloroquine was ineffective (65.4611.1%, chloroquine+Ab vs Ab
alone, p,0.05).
(TIF)
Table S1 In silico analysis identifies kinase candidates
for the regulation of GKAP. We interrogated a database
containing proteomic data regarding post-translational modifica-
tions of synaptic proteins (available at http://www.phosphosite.
org/) using the reference sequence of SAPAP1 as query, 38
phospho-peptides were retrieved. The phosphopeptides were
annotated using Scansite and Phosida phosphorylation site
prediction algorithm. Scansite assigned 16 out of 38 phospho-
sites to specific kinases; Phosida identified 28 out of 38 potential
kinase-phosphosite relationships. Kinases potentially able to
phosphorylate GKAP included cdk5, CaMKII, GSK3, PKA,
PKC, Akt, and CK. Seven sites were independently confirmed by
the two algorithms as potential substrates of cdk5 (according to
SAPAP1 reference sequence S134, S403, S437), CaMKII (S666),
PKA (S381). For 5 peptides, no annotation was provided by any
software.
(DOCX)
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